GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy

Journal of Controlled Release

Volumn 171, Issue 2, 2013, Pages 241-250

  Li, Li ^a   Nurunnabi, Md ^b   Nafiujjaman, Md ^b   Lee, Yong Kyu ^b   Huh, Kang Moo ^a  

^a Chungnam National University   (South Korea)

^b Chungju National University   (South Korea)

Author keywords

Glutathione (PubChem CID: 124886); Gold nanoparticle (PubChem CID: 23985); Heparin (PubChem CID: 772); Pheophorbide a (PubChem CID: 5323510); Photodynamic therapy; Switchable photoactivity

Indexed keywords

FLUORESCENCE; GOLD; GOLD COATINGS; MEDICAL NANOTECHNOLOGY; METAL NANOPARTICLES; NANOPARTICLES; PEPTIDES; PHOTOSENSITIZERS; POLYSACCHARIDES; QUENCHING; TUMORS;

CLINICAL TREATMENTS; FLUORESCENCE QUENCHING; FLUORESCENCE SIGNALS; HYBRID NANOPARTICLE; INTRACELLULAR UPTAKE; PHOTOACTIVITY; PUBCHEM; THERAPEUTIC EFFICACY;

PHOTODYNAMIC THERAPY;

GLUTATHIONE; GOLD NANOPARTICLE; HEPARIN; PHEOPHORBIDE; SINGLET OXYGEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL;

GLUTATHIONE (PUBCHEM CID: 124886); GOLD NANOPARTICLE (PUBCHEM CID: 23985); HEPARIN (PUBCHEM CID: 772); PHEOPHORBIDE A (PUBCHEM CID: 5323510); PHOTODYNAMIC THERAPY; SWITCHABLE PHOTOACTIVITY;

ANIMALS; CELL LINE, TUMOR; CHLOROPHYLL; DRUG CARRIERS; GLUTATHIONE; GOLD; HEPARIN; HUMANS; LIGHT; METAL NANOPARTICLES; MICE; MICE, NUDE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR BURDEN;

EID: 84882348840     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.07.002     Document Type: Article

References (33)

1. D.E. Dolmans, D. Fukumura, R.K. Jain, Photodynamic therapy for cancer, Nat. Rev. Cancer 3 (2003) 380-387. (Pubitemid 37328858)
2. C.J. Gomer, Photodynamic Therapy: Methods and Protocols, Humana Press, New York, 2010.
3. M.R. Hamblin, P. Mroz, Advances in Photodynamic Therapy, Artec House, Boston, 2008.
4. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, Photodynamictherapy, J. Natl. Cancer Inst. 90 (1998) 889-905.
5. I.J. Macdonald, T.J. Dougherty, Basic principles of photodynamic therapy, J. Porphyrins Phthalocyanines 5 (2001) 105-129. (Pubitemid 32125231)
6. M.B. Vrouenraets, G.W.M. Visser, G.B. Snow, G.A.M.S. van Dongen, Basic principles, applications in oncology and improved selectivity of photodynamic therapy, Anticancer Res. 23 (2003) 502-522.
7. A.P. Castano, T.N. Demidova, M.R. Hamblin, Mechanisms in photodynamic therapy: part three-photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction, Photodiagn. Photodyn. Ther. 2 (2005) 91-106. (Pubitemid 41160479)
8. S.J. Lee, K. Park, Y. Oh, S. Kwon, S. Her, I. Kim, K. Choi, S.J. Lee, H. Kim, S.G. Lee, K. Kim, I.C. Kwon, Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice, Biomaterials 30 (2009) 2929-2939.
9. F. Li, B. Bae, K. Na, Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells, Bioconjug. Chem. 21 (2010) 1312-1320.
10. K. Knop, A.F. Mingotaud, N. El-Akra, F. Violleau, J.P. Souchard, Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-ε-caprolactone) micelles for photodynamic therapy, Photochem. Photobiol. Sci. 8 (2009) 396-404.
11. G.A.M.S. van Dongen, G.W.M. Visser, M.B. Vrouenraets, Photosensitizer-antibody conjugates for detection and therapy of cancer, Adv. Drug Deliv. Rev. 56 (2004) 31-52. (Pubitemid 38045423)
12. J. Gravier, R. Schneider, C. Frochot, T. Bastogne, F. Schmitt, J. Didelon, F. Guillemin, M. Barberi-Heyob, Improvement of meta- tetra(hydroxyphenyl) chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies, J. Med. Chem. 51 (2008) 3867-3877. (Pubitemid 351956516)
13. B. Duncan, C. Kim, V.M. Rotello, Gold nanoparticle platforms as drug and biomacromolecule delivery systems, J. Control. Release 148 (2010) 122-127.
14. D.T. Nguyen, D.J. Kim, K.S. Kim, Controlled synthesis and biomolecular probe application of gold nanoparticles, Micron 42 (2011) 207-227.
15. P.C. Chen, S.C. Mwakwari, Gold nanoparticles: from nanomedicine to nanosensing, Nanotechnol, Sci. Appl. 1 (2008) 45-66.
16. X. Huang, M.A. El-Sayed, Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy, J. Adv. Res. 1 (2010) 13-28.
17. R. Hong, G. Han, J.M. Fernandez, B. Kim, N.S. Forbes, V.M. Rotello, Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers, J. Am. Chem. Soc. 128 (2006) 1078-1079. (Pubitemid 43190611)
18. Y. Cheng, A.C. Samia, J.D. Meyers, I. Panagopoulos, B.W. Fei, C. Burda, Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer, J. Am. Chem. Soc. 130 (2008) 10643-10647.
19. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, Z. Zhong, Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery, J. Control. Release 152 (2011) 2-12.
20. Q. Wang, S. Wang, Y. Ding, K. Peng, X. Lin, X. Qiao, Y. Liu, C. Wu, Age-related changes of the redox state of glutathione in plasma, Chin. Med. J. 118 (2005) 1560-1563. (Pubitemid 41404208)
21. M.E. Anderson, Glutathione: an overview of biosynthesis and modulation, Chem. Biol. Interact. 112 (1998) 1-14. (Pubitemid 28271929)
22. A. Russo, W. DeGraft, N. Friedman, J.B. Mitchell, Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs, Cancer Res. 46 (1986) 2845-2848. (Pubitemid 16074292)
23. M.P. Gamcsik, M.S. Kasibhatla, S.D. Teeter, O.M. Colvin, Glutathione levels in human tumors, Biomarkers 17 (2012) 671-691.
24. W.C.W. Chan, Bio-Applications of Nanoparticles, Springer Science, Business Media, 2007.
25. P. Ghosh, G. Han, M. De, C.K. Kim, V.M. Rotello, Gold nanoparticles in delivery applications, Adv. Drug Deliv. Rev. 60 (2008) 1307-1315.
26. R.J. Linhardt, 2003 Claude S. Hudson award address in carbohydrate chemistry. Heparin: structure and activity, J. Med. Chem. 46 (2003) 2551-2564. (Pubitemid 36702523)
27. S.A. Mousa, L.J. Petersen, Anti-cancer properties of low-molecular-weight heparin: preclinical evidence, Thromb. Haemost. 102 (2009) 258-267.
28. V. Bobek, J. Kovarík, Antitumor and antimetastatic effect of warfarin and heparins, Biomed. Pharm. 58 (2004) 213-219. (Pubitemid 38746746)
29. T.M. Niers, C.P. Klerk, M. Dinisio, C.J. van Noorden, H.R. Büller, P.H. Reitsma, D.J. Richel, Mechanisms of heparin induced anti-cancer activity in experimental cancer models, Crit. Rev. Oncol. Hematol. 61 (2007) 195-207. (Pubitemid 46329424)
30. L. Li, B. Bae, T.H. Tran, K.H. Yoon, K. Na, K.M. Huh, Self-quenchable biofunctional nanoparticles of heparin-folate-photosensitizer conjugates for photodynamic therapy, Carbohydr. Polym. 86 (2011) 708-715.
31. K.C. Grabar, R.G. Freeman, M.B. Hommer, M.J. Natan, Preparation and characterization Au colloid monolayers, Anal. Chem. 67 (1995) 735-743.
32. K.D. Sattler, Handbook of Nanophysics: Principles and Methods, Taylor & Francis, 2010.
33. E. Dulkeith, A.C. Morteani, T. Niedereichholz, T.A. Klar, J. Feldmann, S.A. Levi, F.C.J.M. van Veggel, D.N. Reinhoudt, M. Moller, D.I. Gittins, Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects, Phys. Rev. Lett. 89 (2002).